160 related articles for article (PubMed ID: 21742674)
21. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.
Taniyama Y; Tachibana K; Hiraoka K; Aoki M; Yamamoto S; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Morishita R
Gene Ther; 2002 Mar; 9(6):372-80. PubMed ID: 11960313
[TBL] [Abstract][Full Text] [Related]
22. [Cardiovascular gene therapy].
Hansen PR
Ugeskr Laeger; 1997 Nov; 159(48):7124-8. PubMed ID: 9417717
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
Khan TA; Sellke FW; Laham RJ
Gene Ther; 2003 Feb; 10(4):285-91. PubMed ID: 12595887
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy in the treatment of peripheral arterial disease.
Mughal NA; Russell DA; Ponnambalam S; Homer-Vanniasinkam S
Br J Surg; 2012 Jan; 99(1):6-15. PubMed ID: 22068822
[TBL] [Abstract][Full Text] [Related]
25. Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study.
Henry TD; Hirsch AT; Goldman J; Wang YL; Lips DL; McMillan WD; Duval S; Biggs TA; Keo HH
Gene Ther; 2011 Aug; 18(8):788-94. PubMed ID: 21430785
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic angiogenesis by angiogenic growth factor].
Makino H; Ogihara T; Morishita R
Nihon Rinsho; 2003 Apr; 61 Suppl 4():692-7. PubMed ID: 12735051
[No Abstract] [Full Text] [Related]
27. Cardiovascular gene therapy: current status and therapeutic potential.
Gaffney MM; Hynes SO; Barry F; O'Brien T
Br J Pharmacol; 2007 Sep; 152(2):175-88. PubMed ID: 17558439
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis and gene therapy in man: dream or reality?
Amant C; Berthou L; Walsh K
Drugs; 1999; 58 Spec No 1():33-6. PubMed ID: 10526956
[TBL] [Abstract][Full Text] [Related]
29. Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
Francis SC; Raizada MK; Mangi AA; Melo LG; Dzau VJ; Vale PR; Isner JM; Losordo DW; Chao J; Katovich MJ; Berecek KH
Physiol Genomics; 2001 Dec; 7(2):79-94. PubMed ID: 11773594
[TBL] [Abstract][Full Text] [Related]
30. In vivo study of angiogenic plasmid preparations--the bicistronic plasmid as a new type of drug for vascular diseases.
Małecki M; Swoboda P; Jastrzebski Z; Janik P
Acta Pol Pharm; 2004; 61(4):289-95. PubMed ID: 15575596
[TBL] [Abstract][Full Text] [Related]
31. [Adenovirus vectors and their clinical application in gene therapy].
Adám E; Nász I
Orv Hetil; 2001 Sep; 142(38):2061-70. PubMed ID: 11697063
[TBL] [Abstract][Full Text] [Related]
32. [Gene therapy in cardiovascular diseases].
Attramadal H; Berg K
Tidsskr Nor Laegeforen; 2001 Feb; 121(4):489-91. PubMed ID: 11255869
[TBL] [Abstract][Full Text] [Related]
33. Enhanced therapeutic angiogenesis by cotransfection of prostacyclin synthase gene or optimization of intramuscular injection of naked plasmid DNA.
Hiraoka K; Koike H; Yamamoto S; Tomita N; Yokoyama C; Tanabe T; Aikou T; Ogihara T; Kaneda Y; Morishita R
Circulation; 2003 Nov; 108(21):2689-96. PubMed ID: 14568901
[TBL] [Abstract][Full Text] [Related]
34. Potential gene therapy strategies in the treatment of cardiovascular disease.
Rowland RT; Cleveland JC; Meng X; Harken AH; Brown JM
Ann Thorac Surg; 1995 Sep; 60(3):721-8. PubMed ID: 7677519
[TBL] [Abstract][Full Text] [Related]
35. [The latest review of therapeutic angiogenesis using angiogenic growth factors to peripheral arterial diseases].
Aoki M; Ogihara T; Morishita R
Nihon Rinsho; 2002 Sep; 60(9):1845-55. PubMed ID: 12233086
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
37. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
[TBL] [Abstract][Full Text] [Related]
38. Angiogenic gene therapy strategies for the treatment of cardiovascular disease.
Rasmussen HS; Rasmussen CS; Macko J; Yonehiro G
Curr Opin Mol Ther; 2002 Oct; 4(5):476-81. PubMed ID: 12435049
[TBL] [Abstract][Full Text] [Related]
39. Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
Hedman M; Hartikainen J; Ylä-Herttuala S
Gene Ther; 2011 Aug; 18(8):743-9. PubMed ID: 21490683
[TBL] [Abstract][Full Text] [Related]
40. A balancing act: therapeutic approaches for the modulation of angiogenesis.
Springer ML
Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
